The Future of Clinical Trials: Incyte’s Roadmap to Inclusive Patient Representation

แชร์
ฝัง
  • เผยแพร่เมื่อ 5 ก.พ. 2025
  • FULL INTERVIEW
    In this insightful interview, Ryan Brown, Regional Vice President of Trial Landscape at H1, sits down with Dija Atta and Stacy Eckstein from Incyte to discuss the company’s groundbreaking approach to enhancing diversity and inclusion in clinical trials. Dija, Head of Regional Clinical Operations for North America, and Stacy, leader of the Global Site Identification and Feasibility Team, share their experiences with Incyte’s iDIRECT initiative (Insight, Diversity, Inclusion, Representation, and Equity in Clinical Trials), dedicated to improving representation of underrepresented patients.
    The conversation explores Incyte’s use of data-driven strategies, including epidemiological insights and real-time patient enrollment dashboards, to identify diverse sites and participants. Discover how their innovative roadmap aligns with FDA guidelines and uses internal and external data to optimize site selection, boost patient diversity, and overcome participation barriers.
    This discussion highlights Incyte’s mission to foster a more inclusive future in clinical research and offers a behind-the-scenes look at the complexities and passion driving diversity in clinical trials.
    #ClinicalTrials #DiversityInClinicalTrials #Incyte #H1 #ClinicalResearch #Inclusion #HealthcareInnovation #DataDriven

ความคิดเห็น •